𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Changes in the plasma abnormal prothrombin level following treatment of hepatocellular carcinoma

✍ Scribed by Mitsuo Kusano; Masami Nakanishi; Takashi Matsushima; Shin-ichi Sakamoto; Chihiro Sekiya; Yoshie Une; Mitsuo Suga; Akio Kawamura; Kazumitsu Koito; Yoichi Uekita; Junji Fujisawa; Michio Mito


Publisher
Springer
Year
1992
Tongue
English
Weight
305 KB
Volume
31
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Serum levels of des-Ξ³-carboxy prothrombi
✍ Hiroaki Okuda; Toshimi Nakanishi; Kazuko Takatsu; Akiko Saito; Naoaki Hayashi; K πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 1 views

## BACKGROUND. Des-β₯-carboxy prothrombin (DCP) is an established marker for hepatocellular carcinoma (HCC), but the conventional enzyme immunoassay (EIA) kit lacks adequate sensitivity. Thus, a revised EIA kit with increased sensitivity has been developed. In this kit, the sensitivity has increased

Changes in the levels of integrin and fo
✍ Ning Wen Zhu; Claire M. Perks; Andrew R. Burd; Jeff M.P. Holly πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 241 KB πŸ‘ 1 views

Despite the increase in laser therapy, concern remains that sublethal treatment of pre-malignant lesions may adversely affect the biological behaviour of surviving cells. Integrin receptors mediate interaction of cells with the extracellular matrix and their occupation leads to focal adhesion kinase